Article
HIV genotypic resistance among pregnant women initiating ART in Uganda: a baseline evaluation of participants in the Option B+ clinical trial.
African health sciences - 1 Dec 2022
Amone Alexander, Wavamunno Priscilla, Gabagaya Grace, Rukundo Gordon, Namale-Matovu Joyce, Malamba Samuel S, Lubega Irene, Homsy Jaco, King Rachel, Nakabiito Clemensia, Nolan Monica, Fowler Mary Glenn, Musoke Philippa
Abstract excerpt
Background: Pre-treatment HIV drug resistance is a threat to elimination of mother to child HIV transmission and could lead to virological failure among HIV-positive pregnant women. We analysed genotypic HIV drug resistance (HIVDR) of baseline samples of participants enrolled in the Option B+ clinical trial in Uganda. Methods: HIV-infected pregnant women attending antenatal care were enrolled from Uganda's...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
